Featuring: Urooj K. Malik, PharmD Candidate c/o 2024 By: Isabelle Lim, PharmD Candidate c/o 2024 Urooj is a sixth-year pharmacy student at St. John’s University. Throughout her time at St. John’s Urooj has held positions in organizations like the American Association of Psychiatric Pharmacists, Phi Lambda Sigma, International Society of Pharmacoeconomics & Outcomes, Lambda Kappa…

By: Sairah Sheikh, PharmD Candidate c/o 2024 In a world where people are becoming increasingly health-conscious, organic food is of interest to many. It is often seen as the pinnacle of healthy food, although may not be affordable for all. Those who can afford it spend thousands of dollars a year on organic food and…

By: Celestine Van Sertima, PharmD Candidate c/o 2027 Addressing the Issue As the spring season leads the way to respiratory challenges, there have been growing concerns over the shortage of respiratory medications which have raised many problems for people’s health. Specifically, a lack of albuterol metered-dose inhalers (MDIs) has heavily impacted the asthmatic community. Albuterol…

Featuring: Nicole Cernaro, PharmD, PGY-2 Pediatric Pharmacy Resident By: Urooj K. Malik, PharmD Candidate c/o 2024 Nicole Cernaro is a PGY-2 Pediatric Pharmacy Resident at St. Peter’s University Hospital located in New Brunswick, New Jersey. She recently completed her PGY-1 pharmacy residency from St. Peter’s University Hospital as well. Nicole earned her Doctorate in Pharmacy…

By: Imaan Sekhery, PharmD Candidate c/o 2025 On January 6, 2023, the United States (U.S.) Food and Drug Administration (FDA) approved Eisai’s Leqembi (lecanemab), an alternative treatment for Alzheimer’s disease (AD). The creation of the drug depicts a significant advancement within the small field of AD treatments. This disease state is known to begin with…

By: Isabelle Lim, PharmD Candidate c/o 2024 and Hadeel Aldasooky, PharmD Candidate c/o 2024 As the threat of coronavirus disease 2019 (COVID-19) continues to loom over the healthcare world, there is still a need to uncover new treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The COVID-19 Treatment Guidelines Panel’s current recommendation…

By: Geraldine Ciaccio, PharmD Candidate c/o 2025 The personalized weight-loss program WeightWatchers took a significant step into the newly popularized obesity drug market. As one of the leading weight-loss programs in the United States, WeightWatchers customizes diet plans according to individual health goals. To expand its weight management platform into clinical settings, the company agreed…